Source: https://www.mintz.com/our-people/kongsik-kim/experience
Timestamp: 2019-04-23 00:30:58+00:00

Document:
Samsung Electronics Co., Ltd. v. InfoBridge Pte. Ltd., Appeal No. 2018-2007, -2012 (Fed. Cir.) - Representing InfoBridge to keep PTAB’s final written decisions of IPR2017-00099 and -00100 involving a patent directed to a method of constructing merge list (HEVC standard essential patent).
Green Cross Corporation v. Shire Human Genetic Therapies, Inc., Appeal No. 2017-2071 (Fed. Cir.) - Represented Green Cross Corporation to vacate PTAB’s final written decision of IPR2016-00258 involving a patent directed to a purified recombinant iduronate-2-sulfatase.
Industry-Academic Cooperation Foundation, Chosun University v. EMD Millipore Corporation(D. Mass.) - Represented Chosun University to assert patent infringement against EMD, which involved a patent directed to a thiazolidinedione derivative and use thereof.
Adaptive Headlamp Technologies, Inc. v. Hyundai Motor America (D. Del) - Represented Hyundai Motor to defend from Adaptive Headlamp’s assertion of patent infringement, which involved a patent directed to an automatic directional control system for vehicle headlights.
Green Cross Corporation v. Nektar Therapeutics (D. Del.) - Represented Green Cross to assert trade secrets misappropriation against Nektar, which involved polymer-factor VIII moiety conjugates.
NanoEnTek, Inc. and Digital-Bio Technology Co., Ltd. v. Bio-Rad Laboratories, Inc. (E.D. Va.) - Represented NanoEnTek and Digital-Bio to assert patent infringement against Bio-Rad, which involved a patent directed to a method for bonding a plastic micro chip.
DR Systems, Inc. v. Infinitt North America (S. D. Cal.) - Represented Infinitt North to defend from DR Systems’ assertion of patent infringement, which involved a patent directed to an automated system and a method for organizing, presenting, and manipulating medical images.
Boram Pharm. Co. Ltd. v. Life Technologies Corporation (D. Del.). - Represented Boram to assert patent infringement against Life Technologies, which involved a patent directed to a high throughput system for producing recombinant viruses using site-specific recombination.
Genome & Company v. The University of Chicago (PGR2019-00002) - Representing Genome & Company to invalidate a University of Chicago’s patent directed to a method of treating cancer with an immune checkpoint inhibitor combined with a bacterial formulation comprising Bifidobacterium.
Samsung Electronics Co., Ltd. v. M & K Holdings Inc. (IPR2018-00696, -00697, 00698) - Representing M & K Holdings to defend an M & K’s patent directed to an image encoding apparatus and a method of decoding moving picture (HEVC standard essential patent).
Samsung Electronics Co., Ltd. v. InfoBridge Pte. Ltd. (IPR2017-00099, -00100) - Represented InfoBridge to defend an InfoBridge’s patent directed to a method of constructing merge list (HEVC standard essential patent).
SL Corporation v. Adaptive Headamp Technologies, Inc. (IPR2016-00193) - Represented SL Corporation to invalidate an Adaptive Headlamp’s patent directed to an automatic directional control system for vehicle headlights.
Green Cross Corporation v. Shire Human Genetic Therapies, Inc. (IPR2016-00258) - Represented Green Cross to invalidate a Shire Human’s patent directed to a purified recombinant iduronate-2-sulfatase.
Intromedic Co., Ltd. v. Given Imaging Ltd. (IPR2015-00579) -Represented Intromedic to invalidate a Given Imaging’s patent directed to a device for in-vivo Imaging.
Ace Bed Co., Ltd. v. Sealy Technology LLC (IPR2014-01119) - Represented ACE Bed to invalidate a Sealey’s patent directed to a bed spring structure having certain innerspring coils and innersprings with non-helical segments.
Representing a global vehicle manufacturer and a global vehicle parts manufacturer in building patent portfolio.
Representing a global secondary lithium battery manufacturing company in building patentportfolio.
Representing a global display panel manufacturing company in building offensive patent portfolio.
Representing IP asset management companies in building offensive patent portfolio.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.